P&G HYGIENE share price has hit a 52-week high at Rs 9,940 (up 1.61%).
Meanwhile, the BSE 500 Index is at 14,882 (up 0.50%).
Among the top gainers in the BSE 500 Index today are P&G HYGIENE (up 1.61%) and DCM SHRIRAM (up 10.76%)
JBF INDUSTRIES (down 4.95%) and KWALITY DAIRY (down 4.90%) are among the top losers today.
Over the last one year, P&G HYGIENE has moved up from Rs 8,031 to Rs 9,940, registering a gain of Rs 1,908 (up 19.54%).
The BSE 500 has moved up from 13,287 to 14,882, registering a gain of 1,595 points (up 11.89%) during the last 12 months.
The top gainers among the BSE 500 Index stocks during this same period were INDIABULLS VENTURES (up 223.73%), RADICO KHAITAN (up 220.20%) and FIRSTSOURCE SOL. (up 154.95%).
What About the Benchmark Indices?
The BSE Sensex is at 35,726 (up 0.57%). The top gainers among the BSE Sensex stocks today are DR. REDDYS LAB (up 4.67%), SBI (up 2.21%) and TCS (up 1.51%). Other gainers include SUN PHARMA (up 1.42%) and INDUSIND BANK (up 1.34%). The most traded stocks in the BSE Sensex are ADANI PORTS & SEZ and SBI.
In the meantime, NSE Nifty is at 10,856 (up 0.42%). LUPIN LTD (up 5.13%) and SBI (up 2.03%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 31,096 to 35,726, registering a gain of 4,630 points (up 14.76%).
P&G HYGIENE Financial Update...
P&G HYGIENE net profit declined 36.6% YoY to Rs 832 million for the quarter ended March 2018, compared to a loss of Rs 1 billion a year ago. Net Sales rose 80.8% to Rs 5.7 billion during the period as against Rs 7.0 billion in January-March 2017.
For the year ended June 2017, P&G HYGIENE reported 2.4% increase in net profit to Rs 4.3 billion compared to net profit of Rs 4.2 billion during FY16.
Revenue of the company grew 3.0% to Rs 24 billion during FY17.
The current Price to earnings ratio of P&G HYGIENE, based on rolling 12 month earnings, stands at 76.4x.
This article was originally published in English at www.equitymaster.com
Read the complete Indian stock market update. For the terms of use, go here.
No comments:
Post a Comment